Breast cancer is the leading cause of cancer-related deaths in women. In many forms of the disease, tumour growth is driven by estrogen receptors. We are developing an oral, next-generation selective estrogen receptor degrader (SERD) – a medicine designed to stop the growth of cancer cells – as part of our commitment to transform the lives of patients.

Learn more about how we are leading a revolution in oncology to redefine cancer care: [ Ссылка ]

------------------------------------------------------------------------

Global site: [ Ссылка ]
Careers site: [ Ссылка ]

Follow us:
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]

свернуть